SEC Form 4 · accession 0001055726-17-000017
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Morton Collins
Director
Period of report
Mar 27, 2017
Accepted (ET)
Mar 28, 2017 · 2:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 27, 2017 | P | 21,300 | $6.253 | A | 50,000 | I | By Morton Collins IRA account |
| Common Stock | holding | — | — | — | 142,291 | D | ||
| Common Stock | holding | — | — | — | 6,650 | I | By Spouse IRA account | |
| Common Stock | holding | — | — | — | 6,450 | I | By Spouse | |
| Common Stock | holding | — | — | — | 64,750 | I | By Collins Children's Trust | |
| Common Stock | holding | — | — | — | 4,500 | I | The Collins Family Foundation Trust | |
| Common Stock | holding | — | — | — | 64,750 | I | By Collin Grandchildren's Trust |
Table II — derivative securities
No Table II lines on this filing.